Supernus Pharmaceuticals, Inc. (SUPN)
28.61
+0.26
(+0.92%)
USD |
NASDAQ |
Nov 20, 16:00
28.21
-0.40
(-1.40%)
After-Hours: 20:00
Supernus Pharmaceuticals Total Return Level : 37.12 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 37.12 |
| November 19, 2026 | 36.78 |
| November 18, 2026 | 37.57 |
| November 17, 2026 | 37.68 |
| November 16, 2026 | 37.40 |
| November 13, 2026 | 38.56 |
| November 12, 2026 | 37.88 |
| November 11, 2026 | 38.21 |
| November 10, 2026 | 37.30 |
| November 09, 2026 | 35.83 |
| November 06, 2026 | 33.94 |
| November 05, 2026 | 34.69 |
| November 04, 2026 | 36.60 |
| November 03, 2026 | 36.52 |
| November 02, 2026 | 36.52 |
| October 30, 2026 | 42.20 |
| October 29, 2026 | 42.12 |
| October 28, 2026 | 41.35 |
| October 27, 2026 | 41.23 |
| October 26, 2026 | 41.04 |
| October 23, 2026 | 40.97 |
| October 22, 2026 | 42.35 |
| October 21, 2026 | 41.48 |
| October 20, 2026 | 41.50 |
| October 19, 2026 | 40.10 |
| Date | Value |
|---|---|
| October 16, 2026 | 38.13 |
| October 15, 2026 | 39.83 |
| October 14, 2026 | 40.45 |
| October 13, 2026 | 42.29 |
| October 12, 2026 | 43.09 |
| October 09, 2026 | 42.95 |
| October 08, 2026 | 42.42 |
| October 07, 2026 | 43.34 |
| October 06, 2026 | 43.11 |
| October 05, 2026 | 43.04 |
| October 02, 2026 | 42.66 |
| October 01, 2026 | 42.46 |
| September 30, 2026 | 43.33 |
| September 29, 2026 | 44.26 |
| September 28, 2026 | 44.90 |
| September 25, 2026 | 42.94 |
| September 24, 2026 | 43.58 |
| September 23, 2026 | 43.68 |
| September 22, 2026 | 44.04 |
| September 21, 2026 | 43.06 |
| September 18, 2026 | 42.28 |
| September 17, 2026 | 43.21 |
| September 16, 2026 | 41.66 |
| September 15, 2026 | 41.55 |
| September 14, 2026 | 41.77 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ANI Pharmaceuticals, Inc. | 68.55 |
| Prestige Consumer Healthcare, Inc. | 49.63 |
| Structure Therapeutics, Inc. | 16.13 |
| Corcept Therapeutics, Inc. | 63.62 |
| Veru, Inc. | 2.268 |